Search
for
Sort by
Research 121–150 of 385
- Crafting Polymeric and Peptidic Hydrogels for Improved Wound Healing
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Dermatologic Care of the Transplant Patient
- Novel drugs of United States Food and Drug Administration approved in 2024
- Comparison of intralesional triamcinolone acetonide alone and with 5 -fluorouracil for the treatment of keloids
- Niosomes as Carrier in Dermal Drug Delivery
- Miscellaneous Steroids
- Farmácia Lusitana, Vila do Conde e nos Serviços Farmacêuticos do Hospital CUF, Porto
- The pharmacology of methotrexate
- Cutaneous drug reactions
- Cutaneous Reactions to Drugs
- Translating Resveratrol Research: A Systematic Review on Patents and Clinical Trials (2000–2025)
- Phytochemistry, pharmacological activity, and potential health benefits of Glycyrrhiza glabra
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Alopecia With Endocrine Therapies in Patients With Cancer
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- A review on phytochemical, ethnomedical and pharmacological studies on genus Sophora, Fabaceae
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin
- Moderne Untersuchungsmethoden zur Evaluation von Haarausfall und Alopezie bei Frauen
- Topical delivery of nanoemulsions for skin cancer treatment
- Revisiting the role of melatonin in human melanocyte physiology: A skin context perspective
- Application of Scaffold-Based Drug Delivery in Oral Cancer Treatment: A Novel Approach
- Pharmacological Activity of Cepharanthine
- Long-acting microneedle formulations
- Anticancer Effects of Broccoli Sprout Extract and Sulforaphane Through ROS-Induced MAPK Pathway in Breast Cancer Cells and Xenografts
- Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation
- BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer
- Hair & Cutaneous Development